Data / Form D filings / ARBOR PHARMACEUTICALS INC
ARBOR PHARMACEUTICALS INC: Form D filings
ARBOR PHARMACEUTICALS INC, a pharmaceuticals company in Atlanta, Georgia, filed 2 Form D notices with the SEC in 2010. The latest, on December 10, 2010, reports $17.4 million sold of a $17.4 million offering to 10 investors.
Find out what ARBOR PHARMACEUTICALS INC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 980 Hammond Drive, Suite 1250, Atlanta, Georgia, 30328
- Phone
- (919) 792-1700
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2006
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 1375746
The full lists. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Form D filings: 44,302 rows, $523.02, or the new rows each week for $92.05 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Dec 10, 2010 | New notice | $17,415,000 | $17,415,000 | $0 | 10 | Nov 5, 2010 | sec.gov |
| Apr 20, 2010 | New notice | $4,600,000 | $4,600,000 | $0 | 7 | Apr 13, 2010 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Marianne Boskamp | Director | |
| Jason Wild | Executive Officer, Director | |
| Allen Chao | Director | |
| John Donofrio | Executive Officer | |
| Michael Fedida | Director | |
| Joshua Disbrow | Executive Officer | |
| Todd Sone | Director | |
| Edward Schutter | Executive Officer, Director | |
| Jarrett Disbrow | Executive Officer |
Every Form D from the week of Dec 6, 2010 · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what ARBOR PHARMACEUTICALS INC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.